Hypertension Clinical Trials in New York

Showing 81-100 of 143 trials

Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart

NCT01961323

To investigate whether treatment with Nebivolol in subjects with high blood pressure and abnormal filling of left ventricle (LVDD) improves exercise time by improving Left Ventricular deformation and filling.

HypertensionLeft Ventricular Diastolic Dysfunction

Icahn School of Medicine at Mount Sinai70 participantsStarted Mar 2012

New York, New York, United States

COMPLETEDPHASE3< 1 mile

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

NCT01151410

The purpose of this study is to evaluate in a randomized, double-blind fashion, the long-term safety, tolerability and efficacy profile of aliskiren compared to the active comparator enalapril in children, 6 - 17 years old with hypertension (msSBP ≥ 95th percentile for age, gender and height, at baseline in study CSPP100A2365). Patients will be randomized to receive either aliskiren or enalapril. Weight-group based doses of aliskiren or enalapril will be administered once daily and children will receive study medication in a double-blind manner. This study is being conducted to support monotherapy registration of aliskiren for the treatment of hypertension in pediatric patients 6-17 years of age (age at baseline in Study CSPP100A2365).

Hypertension

Novartis Pharmaceuticals208 participantsStarted Aug 2010

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +33 more locations

Effect of Nebivolol on the Blood Flow in Hearts of Adults With High Blood Pressure and Abnormal Filling of Heart

An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age

Hypertension Trials in Other Cities

Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)

Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension

Safety Study of Lisinopril in Children and Adolescents With a Kidney Transplant

Sildenafil Trial of Exercise Performance in Idiopathic Pulmonary Fibrosis

A Behavioral Intervention To Improve Hypertension Control In Veterans

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension

The Role of Echocardiographic Contrast (Optison) in Enhancing Tricuspid Regurgitation Spectral Doppler Signals

Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension (PAH)

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Evaluation of Netarsudil (AR-13324) Ophthalmic Solution in Patients With Glaucoma and Ocular Hypertension

Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease

Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure

Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

Effects of Ventavis in Patients With Pulmonary Hypertension (PH) Secondary to Chronic Obstructive Pulmonary Disease (COPD)

Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

Efficacy, Safety and Tolerability of Multiple Doses of Valsartan in Children With Hypertension With or Without CKD

Other Conditions in New York